European Biotech Acquisition Corp - Warrants (06/03/2026)
EBACW
Get informed when a big investor buys or sells
+ FollowMarket Cap$183.5M
Close$
Share Statistics
| Market cap | $183.50 Million |
|---|---|
| Enterprise Value | $183.19 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.27 |
| Beta | 0 |
| Outstanding Shares | 12,755,000 |
Return
| Return on Equity | 2.89% |
|---|---|
| Return on Assets | 2.70% |
| Return on Invested Capital | -2.19% |
Valuation & Multiples
| P/E Ratio | 40.73 |
|---|---|
| PEG | -29.58 |
| Price to Sales | - |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -65.01 |
| Enterprise Value to Net Income | 52 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About European Biotech Acquisition Corp
2 employeesEuropean Biotech Acquisition Corp. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to fo...